Accessibility Menu
 
Brain Biotech Ag logo

Brain Biotech Ag

(ETR) BNN

Current Price$2.38
Market Cap$57.46M
Since IPO (2016)-71%
5 Year-73%
1 Year-2%
1 Month-15%

Brain Biotech Ag Financials at a Glance

Market Cap

$57.46M

Revenue (TTM)

$61.90M

Net Income (TTM)

$11.23M

EPS (TTM)

$-0.54

P/E Ratio

-4.89

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$2.38

Volume

12,199

Open

$2.51

Previous Close

$2.38

Daily Range

$2.36 - $2.56

52-Week Range

$1.80 - $3.89

BNN News

No articles available.

BNN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Brain Biotech Ag

Industry

Chemicals

Sector

Materials

Employees

264

CEO

Adriaan Moelker, MBA

Headquarters

Zwingenberg, 64673, DE

BNN Financials

Key Financial Metrics (TTM)

Gross Margin

28%

Operating Margin

-13%

Net Income Margin

-18%

Return on Equity

-162%

Return on Capital

-16%

Return on Assets

-17%

Earnings Yield

-20.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$57.46M

Shares Outstanding

21.85M

Volume

12.20K

Short Interest

0.00%

Avg. Volume

9.15K

Financials (TTM)

Gross Profit

$2.01M

Operating Income

$8.51M

EBITDA

$4.17M

Operating Cash Flow

$9.23M

Capital Expenditure

$1.53M

Free Cash Flow

$10.76M

Cash & ST Invst.

$6.32M

Total Debt

$24.03M

Brain Biotech Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$11.92M

-9.0%

Gross Profit

$316.00K

-95.6%

Gross Margin

2.65%

N/A

Market Cap

$57.46M

N/A

Market Cap/Employee

$194.12K

N/A

Employees

296

N/A

Net Income

$2.91M

+27.8%

EBITDA

$929.00K

+40.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$49.95M

-380.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$49.95M

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-16.78%

N/A

Return on Invested Capital

-16.18%

N/A

Free Cash Flow

$5.32M

-115.7%

Operating Cash Flow

$4.28M

-369.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AJ91.DEDocCheck AG
$11.60+2.65%
GS9.FH100 Group AB N
$0.13+0.00%
M3V.DEMeVis Medical Solutions AG
$22.20-2.63%
93M1.DEMPH Health Care AG
$18.15-0.27%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About BNN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.